Stay updated on LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial
Sign up to get notified when there's something new on the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page.

Latest updates to the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page
- CheckyesterdayChange DetectedA new revision label v3.7.0 was added and the previous v3.6.6 label was removed on the Record History page, indicating a software version update to the page. This change reflects a backend/version update rather than any change to the study record content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision history now shows a new release labeled v3.6.6 replacing the previous v3.6.5. This updates the page's version history to reflect the latest update.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry v3.6.5 appears in the study history, replacing the previous v3.6.4. This indicates the record was updated to a new version after QC, without substantive changes to the study information.SummaryDifference0.0%

- Check50 days agoChange DetectedThe record history now shows a new revision entry (v3.6.4). The prior revision (v3.6.3) is removed from the list.SummaryDifference0.0%

- Check79 days agoChange DetectedThe study history now includes a new revision entry v3.6.3. The previous revision v3.6.0 has been removed.SummaryDifference0.0%

- Check93 days agoChange DetectedThe history shows the study is no longer recruiting participants and updates the record to revision v3.6.0, replacing v3.5.5.SummaryDifference0.2%

Stay in the know with updates to LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page.